Hybridoma Myeloma Cell Culture Media
- (11)
- (6)
- (3)
- (8)
- (3)
- (5)
- (4)
- (8)
- (3)
- (9)
- (4)
- (1)
- (11)
- (2)
- (4)
- (1)
- (4)
- (4)
- (3)
- (6)
- (3)
- (8)
Filtered Search Results
Gibco™ Hybridoma-SFM
Greener Choice Product
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
Specifically developed to support the growth of hybridomas for antibody production
| Shipping Condition | Room Temperature |
|---|---|
| Content And Storage | Storage conditions: 2-8°C. Protect from light Shipping conditions: Ambient Shelf life: 12 months from date of manufacture |
| With Additives | Glutamine,Phenol Red |
| Product Type | Serum Free Medium (SFM) |
| Form | Liquid |
| Classification | Low Protein,Serum-free |
| Product Line | Gibco |
| Serum Level | Serum-free |
| Cell Type | Hybridomas |
Gibco™ PFHM-II Protein-Free Hybridoma Medium (liquid)
Greener Choice Product
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
Serum-free, protein-free medium specifically developed for the ability to support the growth of hybridomas for antibody production
Gibco™ CD Hybridoma Medium
Greener Choice Product
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
Specifically developed for the growth of hybridomas and myelomas and monoclonal antibody production
Gibco™ PFHM-II Protein-Free Hybridoma Medium (powder)
Serum-free, protein-free medium specifically developed for the ability to support the growth of hybridomas for antibody production
Cytiva HyClone™ CDM4MAb Powdered Cell Culture Media
ADCF medium for use with hybridoma and myeloma cell lines.
| Content And Storage | 2° to 8°C, away from light |
|---|---|
| Sterilization Method | 0.2 μm Sterile-filtered |
| Product Type | CDM4MAb Liquid Medium |
| Form | Liquid |
| Shelf Life | 12 Months |
Cytiva ADCF-MAb Media
Increase process yields for the manufacture of monoclonal antibodies (MAbs) with HyClone™ ADCF-MAb Media, a protein-free media containing no animal-derived components.
| Content And Storage | 2° to 8°C, away from light |
|---|---|
| Description | with L-Glutamine |
| Sterilization Method | 0.2 μm Sterile-filtered |
| With Additives | Glutamine,Poloxamer 188,HEPES,Sodium Bicarbonate |
| Product Type | ADCF-mAb Liquid Medium |
| Form | Liquid |
| Without Additives | No Protein,No Phenol Red |
| Certifications/Compliance | cGMP |
| Shelf Life | 24 Months |
| Shipping Condition | Wet Ice |
|---|---|
| Content And Storage | Storage conditions: 2-8°C, dark and dry Shipping conditions: Gel packs Shelf life: 24 months from date of manufacture |
| With Additives | Sodium Pyruvate,Sodium Bicarbonate |
| Product Type | Hybridoma Medium |
| Form | Powder (AGT) |
| Classification | Animal Origin-free,Chemically-defined,Protein-free |
| Sterility | Non-sterile |
| Product Line | AGT, Gibco |
| Serum Level | Serum-free |
| Cell Type | Myeloma Cells, Hybridomas |
Cytiva HyClone™ CDM4NS0 Cell Culture Media
Regulatory-friendly medium designed to increase process yields with a variety of NS0 cell clones.
GE Healthcare™ CDM4MAb Liquid Medium without L-glutamine
ADCF medium for use with hybridoma and myeloma cell lines.
Cytiva HyClone™ CDM4PERMAb Powdered Cell Culture Media Without L-glutamine
Chemically defined ADCF media
| Content And Storage | 2 to 8°C |
|---|---|
| Product Type | Hyclone CDM4MAb Media |
| Form | Liquid |
| Without Additives | No Glutamine |
| Quantity | 500 mL |
| Certifications/Compliance | cGMP |
| For Use With (Application) | Production of monoclonal antAntibodies (MAbs) from hybridoma and recombinant myeloma cell lines for research, therapeutic and diagnostic purposes is rapidly growing. |